Five-Year Survival After Transmetatarsal Amputation (TMA)
- Tulsa Cardiovascular Center of Excellence

- Oct 10, 2025
- 2 min read
This summary is based on a retrospective review that examined the five-year mortality rate following a Transmetatarsal Amputation (TMA). A TMA is a minor limb amputation, which is a limb salvage procedure.
Key Findings on Mortality
The study found that the mortality rate following a TMA is significantly lower than that of a Below-Knee Amputation (BKA), demonstrating that TMAs increase patient longevity.
TMA 5-Year Mortality: The study found a 39% five-year mortality rate following the TMA procedure.
This compares to prior literature showing the five-year survival rate for BKA ranging as low as 28% up to 82% , or a mortality rate ranging from 40% to 82%.
Early Mortality: Of the patients who were deceased, 33% expired within the first 12 months of the TMA. The one-year mortality rate for the overall patient population was 14%.
Patient Longevity: Only 9.3% of the departed patients lived past 5 years.
Patient Demographics and Co-Morbidities
The study reviewed the records of 129 patients who underwent TMA between 2009 and 2011.
Co-Morbidity | Percentage of All Patients (n=129) | Percentage of Deceased Patients (n=54) |
Hypertension (HTN) | 89.9% | 47 (36.4%) |
Diabetes (DM) | 79% , 79.1% | 42 (41.1%) |
Neuropathy | 68% , 68.2% | 37 (42.04%) |
Smoking Status | 62.3% | 33 (40.7%) |
Peripheral Vascular Disease (PVD) | 53% , 52.7% | 29 (42.6%) |
Renal Disease | 45% , 44.96% | 33 (56.89%) |
Coronary Artery Disease (CAD) | 36% | 18 (39.1%) |
The Impact of Renal Disease
The study specifically noted that mortality was higher in patients with renal disease compared to other diseases.
Of the 129 total patients, 45% had renal disease.
Of the deceased patients, a greater percentage suffered from renal diseases (57%) compared to other co-morbidities.
More patients that expired had renal disease (56.89%).
Higher Amputation After TMA
A total of 31 patients (24.03%) in the study required higher amputations after the TMA , which included 26 BKAs (Below-Knee Amputations) and five AKAs (Above-Knee Amputations).
Conclusion
The results support that a TMA is a viable limb salvage procedure that should be considered when applicable, given its association with increased patient longevity compared to major limb amputations like BKAs. The research also highlights that co-morbidities, particularly renal disease, are strongly associated with decreased survival rates after lower extremity amputation.




Comments